Abstract

This paper aims to validate the accuracy of the peak skin dose (D_skin,max) computed by the Dose Map software (DMS)—general electric and establish a local follow-up protocol for the management of patient skin injuries following complex interventional cardiology procedures (ICPs). D_skin,max was computed by the DMS and was simultaneously measured by a dense mesh of 72 thermoluminescent dosemeters for 20 ICP. Measured and computed D_skin,max were compared using Lin’s concordance coefficient (${\rho}_c$). The implementation of a local follow-up strategy was based on a computed D_skin,max of 2 Gy. After eliminating 2 outliers, the average deviation between the two methods was 6% (range: −36 to +40%). Concordance between the two methods was moderate with ${\rho}_c$ (confidence interval) of 0.9128 (0.8541–0.9486). DMS computes D_skin,max with an acceptable accuracy and can be used to setup an individual follow-up process for patients with high skin exposure and risks.

中文翻译：

---

对剂量图软件进行基准测试以用于临床实施，并建立遵循复杂介入心脏病学程序治疗皮肤损伤的局部随访方案。

摘要

本文旨在验证由Dose Map软件（DMS）（通用电气）计算的峰值皮肤剂量（D _skin，max）的准确性，并建立根据复杂的介入性心脏病程序管理患者皮肤损伤的局部随访方案（ICP）。通过DMS计算D _skin，max，并同时通过72个热致发光剂量计的密网对20 ICP进行测量。使用Lin的一致性系数（$ {\ rho} _c $）比较测量和计算的D _skin，max。局部随访策略的实施是基于计算出的D _skin，max2 Gy。消除2个离群值后，两种方法之间的平均偏差为6％（范围：-36至+ 40％）。两种方法之间的一致性中等，$ {\ rho} _c $（置信区间）为0.9128（0.8541 – 0.9486）。DMS以可接受的精度计算D_{皮肤最大值}，可用于为高皮肤暴露和高风险的患者设置单独的随访过程。